Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 Mga view
• 08/09/23
0
0
I-embed
administrator
Mga subscriber
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento